Russian pharmaceutical market volume forecast 2030| ��ƽ��

Forecast pharmaceutical market volume in Russia from 2019 to 2030, by scenario (in trillion Russian rubles)

Characteristic	Target scenario	Inertial scenario
2030	3.31	2.88
2027	2.79	2.5
2025	2.48	2.28
2023	2.17	2.03
2021	1.83	1.79
2019	1.52	1.48

Download

Source

Show detailed source information?

Already a member?

Sources

Release date

April 2019

More information

Region

Russia

Survey time period

2018

Supplementary notes

From the project of the development strategy of the pharmaceutical production in Russia until 2030 by the Ministry of Industry and Trade of Russia that was developed since 2018.
According to the source, the target scenario assumes state financial and non-financial support to businesses in creating a pharmaceutical industry competitive on the global market.
Under the inertial scenario, the key objective of regulators, such as the Ministry of Industry and Trade, Federal Antimonopoly Service, Ministry of Healthcare, and Federal Service for Supervision in the Sphere of Healthcare would be the provision of a minimum necessary set of pharmaceuticals and medical goods for the pharmaceutical security of the country in case of political conflicts and sanctions.

Citation formats

The Russian government planned to double the volume of the domestic pharmaceutical market from 1.52 trillion Russian rubles in 2019 to 3.31 trillion Russian rubles in 2030 under the target scenario. The inertial scenario, which focused on providing security to the pharmaceutical sector in case of international conflicts and sanctions, expected the market volume to reach nearly 2.9 trillion Russian rubles by 2030.